TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

108.50$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-7.5% +11.1% +1,278.7% -42.5% -18.7% -34.5% -2.1%
-14.1% +6.9% -59.3% +21.8% -47.2% +425.3% +16.3%
+50.6% +18.9% +29.9% +9.2% -59.7% +120.2% +16.6%
-15.1% +7.2% -62.1% +9.2% -59.7% +684.8% +18.5%
+170.5% +20.1% +10.2% -25.8%
+9.8% -14.1% -14.0%
-75.8% -40.6% -100.0%
-4.5% -8.5% -24.9% -8.2%
-1.7% +70.0% +112.8% +211.0% -4.7% -47.3% -28.3%
-39.4% +86.9% +16.6% +37.9% +21.2% -53.0% +3.6%
+213.3% +0.8% +153.4% -3.4% +11.1% -10.5% -11.7%
-52.3% +302.6% -28.0% -0.9% +12.5% -75.4% -57.0%
-8.3% +2.1% +1,578.5% -50.7% -21.5% -31.3% +3.0%
+7.9% +0.4% -74.9% +0.0% +0.0% +2.7% +15.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?